These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 8635153)
1. Low frequency of p53 gene mutation and protein expression in mucinous colorectal carcinomas. Hanski C; Tiecke F; Hummel M; Hanski ML; Ogorek D; Rolfs A; Schmitt-Gräff A; Stein H; Riecken EO Cancer Lett; 1996 Jun; 103(2):163-70. PubMed ID: 8635153 [TBL] [Abstract][Full Text] [Related]
2. Expression of p53 protein in invasive colorectal carcinomas of different histologic types. Hanski C; Bornhoeft G; Shimoda T; Hanski ML; Lane DP; Stein H; Riecken EO Cancer; 1992 Dec; 70(12):2772-7. PubMed ID: 1451054 [TBL] [Abstract][Full Text] [Related]
3. Discordance of p53 mutations of synchronous colorectal carcinomas. Eguchi K; Yao T; Konomoto T; Hayashi K; Fujishima M; Tsuneyoshi M Mod Pathol; 2000 Feb; 13(2):131-9. PubMed ID: 10697269 [TBL] [Abstract][Full Text] [Related]
4. Colorectal mucinous adenocarcinoma: the clinicopathologic features and significance of p16 and p53 expression. Lam AK; Ong K; Ho YH Dis Colon Rectum; 2006 Sep; 49(9):1275-83. PubMed ID: 16912910 [TBL] [Abstract][Full Text] [Related]
5. p53 expression in colorectal carcinoma in relation to histopathological features in Ugandan patients. Rambau PF; Odida M; Wabinga H Afr Health Sci; 2008 Dec; 8(4):234-8. PubMed ID: 20589130 [TBL] [Abstract][Full Text] [Related]
6. Mucinous and nonmucinous appendiceal adenocarcinomas: different clinicopathological features but similar genetic alterations. Kabbani W; Houlihan PS; Luthra R; Hamilton SR; Rashid A Mod Pathol; 2002 Jun; 15(6):599-605. PubMed ID: 12065772 [TBL] [Abstract][Full Text] [Related]
7. Clinicopathological characteristics, microsatellite instability, and expression of mucin core proteins and p53 in colorectal mucinous adenocarcinomas in relation to location. Park SY; Lee HS; Choe G; Chung JH; Kim WH Virchows Arch; 2006 Jul; 449(1):40-7. PubMed ID: 16645863 [TBL] [Abstract][Full Text] [Related]
8. Mucin expression, p53 overexpression, and peritumoral lymphocytic infiltration of advanced colorectal carcinoma with mucus component: is mucinous carcinoma a distinct histological entity? Tozawa E; Ajioka Y; Watanabe H; Nishikura K; Mukai G; Suda T; Kanoh T; Hatakeyama K Pathol Res Pract; 2007; 203(8):567-74. PubMed ID: 17679024 [TBL] [Abstract][Full Text] [Related]
9. Molecular pathological subclassification of mucinous adenocarcinoma of the colorectum. Li D; Semba S; Wu M; Yokozaki H Pathol Int; 2005 Dec; 55(12):766-74. PubMed ID: 16287491 [TBL] [Abstract][Full Text] [Related]
10. Targeted deep sequencing of mucinous ovarian tumors reveals multiple overlapping RAS-pathway activating mutations in borderline and cancerous neoplasms. Mackenzie R; Kommoss S; Winterhoff BJ; Kipp BR; Garcia JJ; Voss J; Halling K; Karnezis A; Senz J; Yang W; Prigge ES; Reuschenbach M; Doeberitz MV; Gilks BC; Huntsman DG; Bakkum-Gamez J; McAlpine JN; Anglesio MS BMC Cancer; 2015 May; 15():415. PubMed ID: 25986173 [TBL] [Abstract][Full Text] [Related]
11. Mucinous carcinomas of the colorectum have distinct molecular genetic characteristics. Song GA; Deng G; Bell I; Kakar S; Sleisenger MH; Kim YS Int J Oncol; 2005 Mar; 26(3):745-50. PubMed ID: 15703832 [TBL] [Abstract][Full Text] [Related]
12. Concordance between p53 protein overexpression and gene mutation in a large series of common human carcinomas. Soong R; Robbins PD; Dix BR; Grieu F; Lim B; Knowles S; Williams KE; Turbett GR; House AK; Iacopetta BJ Hum Pathol; 1996 Oct; 27(10):1050-5. PubMed ID: 8892589 [TBL] [Abstract][Full Text] [Related]
13. Expression of MUC2-mucin in colorectal adenomas and carcinomas of different histological types. Blank M; Klussmann E; Krüger-Krasagakes S; Schmitt-Gräff A; Stolte M; Bornhoeft G; Stein H; Xing PX; McKenzie IF; Verstijnen CP Int J Cancer; 1994 Nov; 59(3):301-6. PubMed ID: 7927933 [TBL] [Abstract][Full Text] [Related]
14. p53 mutations and histological type of invasive breast carcinoma. Marchetti A; Buttitta F; Pellegrini S; Campani D; Diella F; Cecchetti D; Callahan R; Bistocchi M Cancer Res; 1993 Oct; 53(19):4665-9. PubMed ID: 8402644 [TBL] [Abstract][Full Text] [Related]
15. Association of p53 accumulation with TP53 mutations, loss of heterozygosity at 17p13, and DNA ploidy status in 273 colorectal carcinomas. Clausen OP; Lothe RA; Børresen-Dale AL; De Angelis P; Chen Y; Rognum TO; Meling GI Diagn Mol Pathol; 1998 Aug; 7(4):215-23. PubMed ID: 9917132 [TBL] [Abstract][Full Text] [Related]
16. Mucin core protein expression by colorectal mucinous carcinomas with or without mucus hyperplasia. Ishizu H; Kumagai J; Eishi Y; Takizawa T; Koike M J Gastroenterol; 2004; 39(2):125-32. PubMed ID: 15069618 [TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical and mutational analyses of beta-catenin, Ki-ras, and p53 in two subtypes of colorectal mucinous carcinoma. Ikeda S; Shimizu Y; Fujimori M; Ishizaki Y; Kurihara T; Ojima Y; Okajima M; Asahara T Clin Cancer Res; 2003 Nov; 9(15):5660-5. PubMed ID: 14654549 [TBL] [Abstract][Full Text] [Related]
18. Overexpression or ectopic expression of MUC2 is the common property of mucinous carcinomas of the colon, pancreas, breast, and ovary. Hanski C; Hofmeier M; Schmitt-Gräff A; Riede E; Hanski ML; Borchard F; Sieber E; Niedobitek F; Foss HD; Stein H; Riecken EO J Pathol; 1997 Aug; 182(4):385-91. PubMed ID: 9306958 [TBL] [Abstract][Full Text] [Related]
19. Correlations of proliferation markers, p53 expression and histological findings in colorectal carcinoma. Georgescu CV; Săftoiu A; Georgescu CC; Ciurea R; Ciurea T J Gastrointestin Liver Dis; 2007 Jun; 16(2):133-9. PubMed ID: 17592558 [TBL] [Abstract][Full Text] [Related]
20. Comparison of p53 gene mutation and protein overexpression in colorectal carcinomas. Dix B; Robbins P; Carrello S; House A; Iacopetta B Br J Cancer; 1994 Oct; 70(4):585-90. PubMed ID: 7917901 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]